Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
N/A
-24,055 Reduced 35.39%
43,923 $202,000
Q4 2023

Feb 13, 2024

BUY
$4.3 - $4.7 $253,962 - $277,586
59,061 Added 662.34%
67,978 $312,000
Q3 2023

Nov 13, 2023

SELL
$0.0 - $4.46 $0 - $90,618
-20,318 Reduced 69.5%
8,917 $39,000
Q2 2023

Aug 14, 2023

BUY
$0.4 - $1.3 $11,694 - $38,005
29,235 New
29,235 $16,000
Q2 2022

Aug 15, 2022

SELL
$1.93 - $8.73 $39,429 - $178,353
-20,430 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$4.42 - $9.0 $39,284 - $79,992
8,888 Added 77.01%
20,430 $169,000
Q4 2021

Feb 01, 2022

BUY
$6.71 - $12.55 $77,446 - $144,852
11,542 New
11,542 $84,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.